Abstract
More than 15 years after the discovery of human immunodeficiency virus (HIV), researchers are still struggling to design a protective AIDS vaccine. A remaining problem is a lack of basic knowledge about the immunological requirements for protection against retroviruses. Infection of macaque monkeys with simian immunodeficiency virus is still the best model for HIV vaccine research. However, in this model it remains difficult to determine protective immunological mechanisms because of limited numbers of experimental animals and their genetic heterogeneity. Thus, fundamental concepts in retroviral immunology have to be defined in other ways such as mouse models. This minireview summarizes new findings on cellular and molecular mechanisms in protection of mice against Friend murine retrovirus infection. It has been shown that complex immune responses, including B and T cell responses, are required for efficient protection in this model. Multiple viral antigens are necessary to elicit such broad immune reactivity. Efficacious vaccines must protect not only against acute disease, but also against the establishment of persistent infections or the host is at serious risk of virus reactivation. The minireview closes with a discussion o...Continue Reading
Citations
Jul 13, 2004·Vaccine·Thorsten ReuterUlf Dittmer
Dec 17, 2009·Journal of Virology·Wibke BayerOliver Wildner
Nov 23, 2007·Journal of Virology·Laurent GrosMarc Piechaczyk
Apr 29, 2005·Journal of Virology·Laurent GrosMarc Piechaczyk
Jul 30, 2005·Journal of Virology·Gennadiy ZelinskyyUlf Dittmer
Aug 13, 2009·Blood·Gennadiy ZelinskyyUlf Dittmer
Apr 15, 2008·BMC Immunology·Matthias TenbuschKlaus Uberla
Jun 12, 2008·PloS One·Justin M GreeneDavid H O'Connor
Oct 16, 2009·The Journal of General Virology·Savita R NairUlf Dittmer
Sep 29, 2011·Retrovirology·Savita NairUlf Dittmer
Jul 30, 2015·Retrovirology·Elisabeth Littwitz-SalomonKathrin Gibbert
Mar 28, 2013·PloS One·Kalani HalemanoMario L Santiago
Dec 18, 2013·PLoS Pathogens·Kirsten K DietzeUlf Dittmer
Jul 24, 2014·PloS One·Minglong LiuRong Zhou
Jan 24, 2007·Vaccine·Antonia RadaelliBéhazine Combadière
Nov 9, 2016·Retrovirology·Elisabeth Littwitz-SalomonKathrin Sutter
Jun 8, 2018·Journal of Virology·Melissa KaneTatyana V Golovkina
Apr 1, 2020·PLoS Pathogens·Paul DavidGennadiy Zelinskyy